Local disinfection for drug delivery system
Apparatus and a method are presented for delivering a therapeutic substance to a subject. A therapeutic substance delivery device includes an ultraviolet radiation source that disinfects a disinfection chamber of the therapeutic device. Control circuitry (a) activates the ultraviolet radiation source to irradiate the disinfection chamber, (b) measures a current input to the ultraviolet radiation source, the current being indicative of intensity of the ultraviolet radiation within the disinfection chamber, and (c) terminates the activation of the ultraviolet radiation source at a time determined based on the measured current. Other embodiments are also described.
1. Apparatus for delivering a therapeutic substance to a subject, the apparatus comprising:
a therapeutic substance delivery device, comprising:
an ultraviolet radiation source configured to disinfect a disinfection chamber of the therapeutic device; and
control circuitry configured to (a) activate the ultraviolet radiation source to irradiate the disinfection chamber with ultraviolet radiation, (b) measure a current input to the ultraviolet radiation source, the current being indicative of intensity at which the ultraviolet radiation source emits ultraviolet radiation, (c) based on the measured current, determine an amount of time that the ultraviolet radiation source should be active for, and (d) terminate the activation of the ultraviolet radiation source after the determined amount of time has elapsed,
wherein:
(A) the control circuitry is configured to sequentially (a) activate the ultraviolet radiation source a first time prior to the apparatus being packaged for commercial sale, (b) terminate the activation of the ultraviolet radiation source, (c) activate the ultraviolet radiation source at least a second time at least 1 month following the apparatus being packaged for commercial sale, and (d) terminate the activation of the ultraviolet radiation source, and
(B) the control circuitry is further configured to, at least one time during the shelf-life of the therapeutic substance delivery device between the first time and the at least a second time: (i) activate the ultraviolet radiation source, and subsequently (ii) terminate the activation of the ultraviolet radiation source.
2. The apparatus according to claim 1 , wherein a surface area of the disinfection chamber is 1-400 mm2.
3. The apparatus according to claim 1 , wherein the ultraviolet radiation source is configured to emit the ultraviolet radiation at a power level of 1-200 mW.
4. The apparatus according to claim 1 , wherein the ultraviolet radiation source is configured to emit the ultraviolet radiation at a wavelength of 100-400 nm.
5. The apparatus according to claim 1 , wherein the ultraviolet radiation source is configured to emit the ultraviolet radiation at a plurality of wavelengths.
6. The apparatus according to claim 1 , wherein at least one surface of the disinfection chamber is a reflective surface configured to reflect the ultraviolet radiation.
7. The apparatus according to claim 6 , wherein the reflective surface is configured to reflect at least 10% of the ultraviolet radiation.
8. The apparatus according to claim 6 , wherein the reflective surface comprises expanded polytetrafluoroethylene (ePTFE).
9. The apparatus according to claim 6 , wherein the reflective surface comprises aluminum.
10. The apparatus according to claim 6 , wherein the reflective surface of the disinfection chamber is configured to focus the ultraviolet radiation to a designated area within the disinfection chamber.
11. The apparatus according to claim 1 , wherein the ultraviolet radiation source comprises an ultraviolet light emitting diode (UV LED), and the control circuitry is configured to measure a current input to the UV LED.
12. The apparatus according to claim 1 , wherein the control circuitry is further configured to activate the therapeutic substance delivery device to deliver the therapeutic substance to the subject.
13. The apparatus according to claim 1 , wherein the control circuitry is configured to activate the disinfection assembly the at least a second time at least 6 months following the apparatus being packaged for commercial sale.